BRD2 and non-small cell lung carcinoma: As indicated in the ROC curves of Figure 5, the combined Cli_Pat_Rad_PET/CT machine learning models outperformed the Cli_Pat machine learning models in prediction of pathological response to NAT for NSCLC.